Terms: = Leukemia AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
159 results:
1. Childhood-onset systemic lupus erythematosus (cSLE) and malignancy: a nationwide multicentre series review.
Brufatto MZ; Lanças SHS; de Albuquerque Pedrosa Fernandes T; Sallum AME; Campos LMA; Sakamoto AP; Terreri MT; Sztajnbok FR; Bica BERG; Ferriani VPL; de Carvalho LM; Silva CAA; Saad-Magalhaes C
Adv Rheumatol; 2024 Feb; 64(1):13. PubMed ID: 38321580
[TBL] [Abstract] [Full Text] [Related]
2. Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study.
Bury D; Wolfs TFW; Muilwijk EW; Fiocco M; Pieters R; Brüggemann RJ; Tissing WJE
Int J Antimicrob Agents; 2024 Jan; 63(1):107058. PubMed ID: 38081549
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemia.
Liu W; Bai Y; Zhou L; Jin J; Zhang M; Wang Y; Lin R; Huang W; Ren X; Ma N; Zhou F; Wang Z; Ding K
Eur J Med Chem; 2024 Jan; 264():115974. PubMed ID: 38007910
[TBL] [Abstract] [Full Text] [Related]
4. Quality by design approach-based fabrication and evaluation of self-nanoemulsifying drug delivery system for improved delivery of venetoclax.
Rajana N; Chary PS; Pooja YS; Bhavana V; Singh H; Guru SK; Singh SB; Mehra NK
Drug Deliv Transl Res; 2024 May; 14(5):1277-1300. PubMed ID: 37953430
[TBL] [Abstract] [Full Text] [Related]
5. Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancies: A Pharmacokinetic Study.
AbdelMagid AM; Abbassi MM; Ebeid FS; Farid SF; El-Sayed MH
Clin Ther; 2024 Jan; 46(1):e12-e22. PubMed ID: 37925363
[TBL] [Abstract] [Full Text] [Related]
6. Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans.
Hofmann J; Bartůněk A; Hauser T; Sedmak G; Beránek J; Ryšánek P; Šíma M; Slanař O
Leukemia; 2023 Dec; 37(12):2486-2492. PubMed ID: 37789147
[TBL] [Abstract] [Full Text] [Related]
7. Despite warnings, co-medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH-dependence, minimizing undesirable drug-drug interactions.
Larfors G; Andersson P; Jesson G; Liljebris C; Brisander M; Lennernäs H; Stenke L
Eur J Haematol; 2023 Oct; 111(4):644-654. PubMed ID: 37503797
[TBL] [Abstract] [Full Text] [Related]
8. Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients.
Sui M; Wei H; Shen X; Gao K; Zhang Z; Zhang Q
Hematology; 2023 Dec; 28(1):2231738. PubMed ID: 37417768
[TBL] [Abstract] [Full Text] [Related]
9. Effects of MYC Inhibitors on the Growth of Acute Leukaemia Cells.
Noguchi K; Itoh M; Ito C; Tohda S
Anticancer Res; 2023 Jul; 43(7):3023-3028. PubMed ID: 37351975
[TBL] [Abstract] [Full Text] [Related]
10. Polyamidoamine Dendrimers Functionalized with ZnO-Chitosan Nanoparticles as an Efficient Surface for L-asparaginase Immobilization.
Iraninasab S; Homaei A; Mosaddegh E; Torkzadeh-Mahani M
Appl Biochem Biotechnol; 2024 Feb; 196(2):971-991. PubMed ID: 37285001
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of Exceptionally Potent, Selective, and Efficacious PROTAC Degraders of CBP and p300 Proteins.
Thomas JE; Wang M; Jiang W; Wang M; Wang L; Wen B; Sun D; Wang S
J Med Chem; 2023 Jun; 66(12):8178-8199. PubMed ID: 37276143
[TBL] [Abstract] [Full Text] [Related]
12. Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study.
Guzelkucuk Z; Karapınar DY; Gelen SA; Tokgoz H; Ozcan A; Ay Y; Bahadır A; Ozbek NY; Oren AC; Ayhan AC; Akyay A; Akıncı B; Karadas N; Unuvar A; Oren H; Fettah A; Kaya Z; Isık B; Eker İ; Karaman S; Yıldırım AT; Orhan MF; Oymak Y; Timur C; Yazici N; Simsek A; Karakurt N; Toret E; Evim MS
Pediatr Blood Cancer; 2023 Aug; 70(8):e30425. PubMed ID: 37194482
[TBL] [Abstract] [Full Text] [Related]
13. Discovery of highly potent HDAC8 PROTACs with anti-tumor activity.
Zhao C; Chen D; Suo F; Setroikromo R; Quax WJ; Dekker FJ
Bioorg Chem; 2023 Jul; 136():106546. PubMed ID: 37098288
[TBL] [Abstract] [Full Text] [Related]
14. A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
Jonas BA; Hou JZ; Roboz GJ; Alvares CL; Jeyakumar D; Edwards JR; Erba HP; Kelly RJ; Röllig C; Fiedler W; Brackman D; Siddani SR; Chyla B; Hilger-Rolfe J; Watts JM
Hematol Oncol; 2023 Oct; 41(4):743-752. PubMed ID: 37086447
[TBL] [Abstract] [Full Text] [Related]
15. Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia.
Yoshimura S; Panetta JC; Hu J; Li L; Gocho Y; Du G; Umezawa A; Karol SE; Pui CH; Mullighan CG; Konopleva M; Stock W; Teachey DT; Jain N; Yang JJ
Leukemia; 2023 Jun; 37(6):1194-1203. PubMed ID: 37076694
[TBL] [Abstract] [Full Text] [Related]
16. Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
Penack O; Peczynski C; Koenecke C; Polge E; Kuhnl A; Fegueux N; Daskalakis M; Kröger N; Dreger P; Besley C; Schanz U; Bloor A; Ganser A; Forcade E; Corral LL; Passweg JR; Novak U; Moiseev I; Schoemans H; Basak GW; Chabannon C; Sureda A; Averbuch D; Glass B; de la Camara R; Peric Z
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072350
[TBL] [Abstract] [Full Text] [Related]
17. MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: max Interaction and Tumor Growth in a MYC-Dependent Manner.
Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson LG
Cancer Res Commun; 2022 Mar; 2(3):182-201. PubMed ID: 36874405
[TBL] [Abstract] [Full Text] [Related]
18. CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries.
Matsuzaki M; Annamalay A; Garcia-Gonzalez P; Radich J
Curr Hematol Malig Rep; 2023 Feb; 18(1):1-7. PubMed ID: 36790617
[TBL] [Abstract] [Full Text] [Related]
19. Relative Bioavailability and Food Effect of Asciminib Pediatric Mini-tablet Formulation Compared to the Reference Tablet Formulation in Healthy Adult Participants.
Hoch M; Bebrevska L; Singh N; Hourcade-Potelleret F
Clin Pharmacol Drug Dev; 2023 May; 12(5):484-492. PubMed ID: 36622274
[TBL] [Abstract] [Full Text] [Related]
20. Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [
Guo F; Liu B; Li X; Wang H; Zhu X; Su Y; He C; Zhu M; Ding J; Xu Y; Zhao X; Wang Y; Shan R; Zhu J; Xie J; Ge Q; Fan L; Ding Y; Xie Y; Zhang C; Li H; Wang H; Zhou H
Cancer Chemother Pharmacol; 2023 Feb; 91(2):143-156. PubMed ID: 36572783
[TBL] [Abstract] [Full Text] [Related]
[Next]
